Hemodynamic changes of systemic, hepatic, and splenic circulation following triglycyl-lysin-vasopressin administration in alcoholic cirrhosis

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Digestive Diseases and Sciences

• Publication date

  1988-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF01535785PMID 3409797
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of vasopressin on portal hemodynamics in patients with portal hypertension.

  1987cited by this paper
• Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis.

  1987cited by this paper
• [Somatostatin and gastric acid secretion].

  1986cited by this paper
• Circulatory actions of vasopressin in anaesthetized rats with portal hypertension subjected to haemorrhage.

  1986cited by this paper
• Effect of nadolol on liver haemodynamics and function in patients with cirrhosis.

  1986cited by this paper
• Terlipressin in bleeding esophageal varices: A placebo‐controlled, double‐blind study

  1986cited by this paper
• [Effects of glypressin on the splanchnic and systemic circulation in patients with cirrhosis].

  1985cited by this paper
• Cronkhite Canada syndrome: a new hypothesis.

  1985cited by this paper
• Splenic haemodynamics and portal hypertension in patients with liver cirrhosis and spleen enlargement.

  1985cited by this paper
• The effect of continuous vasopressin infusion on splanchnic blood flow, liver function, and portal and central venous pressures in patients with cirrhosis.

  1984cited by this paper
• [What form of vasopressin to use for the emergency treatment of ruptured esophageal varices?].

  1984cited by this paper
• Controlled Trial of Vasopressin and Balloon Tamponade in Bleeding Esophageal Varices

  1984cited by this paper
• 初期食道静脈りゅう治療におけるテルイプレシン(グリプレシン)とバソプレシンの比較試験

  1982cited by this paper
• Controlled trial of terlipressin ('Glypressin') versus vasopressin in the early treatment of oesophageal varices.

  1982cited by this paper
• Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension

  1982cited by this paper
• Continuous intravenous vasopressin in active upper gastrointestinal bleeding.

  1982cited by this paper
• Comparison of vasopressin and triglycyl-lysine vasopressin on splanchnic and systemic hemodynamics in dogs

  1980influential reference
• Effects of lysine vasopressin and glypressin on the fibrinolytic system in cirrhosis.

  1979cited by this paper
• [Treatment of bleeding oesophageal varices in cirrhotic patients with pitressin. A controlled study (author's transl)].

  1978cited by this paper
• The Effects of Intra‐arterial and Intraportal Injections of Vasopressin on the Simultaneously Perfused Hepatic Arterial and Portal Venous Vascular Beds of the Dog

  1978cited by this paper
• Action of the triglycyl hormonogen of vasopressin (glypressin) in patients with liver cirrhosis and bleeding esophageal varices.

  1977cited by this paper
• Control of Bleeding Varices by Vasopressin: A Prospective Randomized Study

  1977cited by this paper
• Dose-response relationships for arginine vasopressin and synthetic analogs on three types of rat blood vessels: possible evidence for regional differences in vasopressin receptor sites within a mammal.

  1975cited by this paper
• Die Wirkung von Triglycyl-Lysin-Vasopressin auf Kontrollpersonen und Patienten mit Blutungen des oberen Gastrointestinaltraktes

  1975influential reference
• [The action of triglycylvasopressin on control subjects and patients with upper gastrointestinal bleeding (author's transl)].

  1975cited by this paper
• Radiological determination of spleen size.

  1969cited by this paper
• Splenic blood flow in cirrhosis and portal hypertension.

  1968cited by this paper
• Effect of intravenously administered posterior pituitary extract on hemorrhage from bleeding esophageal varices. A controlled evaluation.

  1962cited by this paper
• The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.

  1961cited by this paper

• Glycyrrhizin Attenuates Portal Hypertension and Collateral Shunting via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats

  2021cites this paper
• Matrix metalloproteinase‐9 inhibition or deletion attenuates portal hypertension in rodents

  2021cites this paper
• Bleeding in portal hypertension.

  2020cites this paper
• Terlipressin for variceal bleeding induces large plasma sodium fluctuations in patients without cirrhosis

  2018cites this paper
• Treatment of bleeding caused by liver cirrhosis-associated portal hypertension – update of Czech Society of Hepatology guidelines

  2017cites this paper
• Vasopressin 1a receptor partial agonism increases sodium excretion and reduces portal hypertension and ascites in cirrhotic rats

  2016cites this paper
• Les effets des substances vasoactives sur les perturbations hémodynamiques, systémiques et splanchniques induites par les états de choc et la cirrhose

  2015cites this paper
• Pharmacologic management of portal hypertension.

  2014cites this paper
• Use of Vasoactive Drugs for Acute Variceal Bleeding

  2014cites this paper
• Hemodynamic effects of continuous versus bolus infusion of terlipressin for portal hypertension: A randomized comparison

  2013cites this paper
• The Use of Vasopressin in the Treatment of Upper Gastrointestinal Haemorrhage

  2012cites this paper
• Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension

  2010cites this paper
• Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis

  2009cites this paper
• Session 8 ‒ Complications in the Medical Treatment of Portal Hypertension

  2008cites this paper
• Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome

  2008cites this paper
• Chronic cyclooxygenase blockade enhances the vasopressin responsiveness in collaterals of portal hypertensive rats

  2006cites this paper
• Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis

  2005cites this paper
• Terlipressina: profilo farmacologico clinico, terapeutico e farmacoeconomico nel trattamento delle varici esofagee

  2005cites this paper
• Hemodynamic Effects of Terlipressin and High Somatostatin Dose during Acute Variceal Bleeding in Nonresponders to the Usual Somatostatin Dose

  2005cites this paper
• Chronic inhibition of nitric oxide increases the collateral vascular responsiveness to vasopressin in portal hypertensive rats.

  2004cites this paper
• [Vasoconstrictive Therapies for Bleeding Esophageal Varices and their Mechanisms of Action].

  2003cites this paper
• Wirkmechanismen der vasokonstriktiven Therapie der Ösophagusvarizenblutung

  2003cites this paper
• Role of spleen enlargement in cirrhosis with portal hypertension.

  2002cites this paper
• Hemodynamic Effects of a Combination of Octreotide and Terlipressin Patients with Viral Hepatitis Related Cirrhosis

  2002cites this paper
• Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis

  2001cites this paper
• Comparative effects of the novel vasotocin analogue F-180 vs. vasopressin and terlipressin on systemic and splanchnic isolated vessels from portal hypertensive rats

  2001cites this paper
• Terlipressin is more effective in decreasing variceal pressure than portal pressure in cirrhotic patients.

  2000cites this paper
• Splanchnic haemodynamics after intravenous terlipressin in anaesthetised healthy pigs.

  1999cites this paper
• Vasopressin reverses mesenteric hyperemia and vasoconstrictor hyporesponsiveness in anesthetized portal hypertensive rats

  1998cites this paper
• Portal‐hypertensive gastropathy

  1998cites this paper
• [Medical treatment of intestinal hemorrhage in portal hypertension].

  1998cites this paper
• Time profile of the haemodynamic effects of terlipressin in portal hypertension.

  1997cites this paper
• The cardiac evaluation of liver transplant recipients: a single center's experience.

  1997cites this paper
• Hemodynamic and metabolic effects of terlipressin in patients with cirrhosis receiving a nonselective beta-blocker.

  1996cites this paper
• Hemodynamic and metabolic effects of terlipressin in patients with cirrhosis receiving a nonselectiveβ-blocker

  1996cites this paper
• Effect of terlipressin on in vitro vascular hyporeactivity of portal hypertensive rats.

  1996cites this paper
• Reduction of gastric hyperemia by glypressin and vasopressin administration in cirrhotic patients with portal hypertensive gastropathy

  1994cites this paper
• Terlipressin (glypressin) in the treatment of bleeding esophageal varices. State of the art.

  1993cites this paper
• Terlipressin vs. Somatostatin in bleeding esophageal varices: A controlled, double‐blind study

  1992cites this paper
• [Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis].

  1992cites this paper
• Effect of triglycyl-lysin-vasopressin on quantitative liver function tests in patients with cirrhosis.

  1992cites this paper
• A randomized controlled study of low‐dose and high‐dose terlipressin in the control of acute oesophageal variceal haemorrhage

  1991cites this paper
• Vasoconstrictor therapy in bleeding esophageal varices.

  1990cites this paper
• Clinical pharmacology of splanchnic circulation in cirrhosis.

  1990cites this paper
• Systemic hemodynamic and cardiac function changes in patients undergoing orthotopic liver transplantation.

  1990cites this paper
• Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices. A double-blind, randomized, placebo-controlled trial.

  1990cites this paper
• [Haemodynamic effect of triglycyl-lysine vasopressin (glypressin) on intravascular oesophageal variceal pressure in patients with cirrhosis. A randomized placebo controlled trial].

  1990cites this paper
• Nitrovasodilators and portal hypertension.

  1990cites this paper
• Systemic and portal haemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis.

  1990cites this paper